Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia

Hui Fang Lim, Jason Phua, Amartya Mukhopadhyay, Wang Jee Ngerng, Mei Ying Chew, Tiong Beng Sim, Win Sen Kuan, Malcolm Mahadevan, Tow Keang Lim
European Respiratory Journal 2014 43: 852-862; DOI: 10.1183/09031936.00081713
Hui Fang Lim
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Hui_Fang_Lim@nuhs.edu.sg
Jason Phua
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amartya Mukhopadhyay
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wang Jee Ngerng
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mei Ying Chew
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiong Beng Sim
2Emergency Dept, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Win Sen Kuan
2Emergency Dept, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malcolm Mahadevan
2Emergency Dept, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tow Keang Lim
1Division of Respiratory and Critical Care Medicine, Dept of Medicine, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The effect of employing severity scores to identify severe community-acquired pneumonia (SCAP) cases for early aggressive resuscitation is unknown. Optimising pre-intensive care unit (ICU) care may improve outcomes in patients at risk of SCAP.

We conducted a before-and-after study of patients classified into control and intervention groups (January 2004 to December 2007 and January 2008 to December 2010, respectively). Our intervention was two-pronged, using the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) minor criteria to identify SCAP for aggressive emergency department resuscitation. Patients with SCAP, defined as those with three or more IDSA/ATS minor criteria, were targeted. Differences in mortality, triage and compliance with emergency department resuscitation were compared between the groups.

The hospital mortality rate was lower in the intervention versus the control group (5.7% versus 23.8%, p<0.001). On multivariate analysis, the intervention group was associated with lower mortality (OR 0.24, 95% CI 0.09–0.67). ICU admission rates decreased from 52.9% to 38.6% (p=0.008) and inappropriately delayed ICU admissions decreased from 32.0% to 14.8% (p<0.001). There was increased compliance with the aggressive resuscitation protocol after the intervention.

A combined intervention, using a pneumonia score to identify those at risk of SCAP early and an aggressive pre-ICU resuscitation protocol may reduce mortality and ICU admissions.

Abstract

IDSA/ATS minor criteria can help identify at-risk SCAP patients for early resuscitation http://ow.ly/rVday

Introduction

Severe community-acquired pneumonia (SCAP) is associated with a high mortality rate (23–50%) and can result in significant healthcare costs [1–3]. It is usually defined as community-acquired pneumonia (CAP) that requires intensive care unit (ICU) admission or mechanical ventilation/vasopressor support. However, ICU admission rates can vary between 3% and 39% in different centres [2], due to differences in local ICU admission criteria, subjective physician assessments and availability of ICU resources. In addition, mechanical ventilation or vasopressor support is not required in all cases. Moreover, there is a category of “at-risk SCAP”, which may be under-recognised because patients may initially have subtle findings. Thus, the 2007 Infectious Disease Society of America (IDSA)/American Thoracic Society (ATS) pneumonia guidelines proposed a set of minor criteria to help identify this group (table 1) [4]. Fulfilment of three out of the nine minor criteria is defined as SCAP. Other pneumonia severity scores such as the SMART-COP (low systolic blood pressure, multilobar chest radiography involvement, low albumin level, high respiratory rate, tachycardia, confusion, poor oxygenation and low arterial pH), CURXO-80 (altered mental status, blood urea nitrogen >30 mg·dL−1, respiratory rate >30 breaths·min−1, systolic blood pressure <90 mmHg, arterial pH <7.30, multilobar/bilateral lung affectation, oxygen arterial pressure <54 mmHg or ratio of arterial oxygen tension to fraction of inspired oxygen <250 mmHg and age >80 years) and risk of early admission (REA)-ICU index were also created with the same intention [5–7]. They perform equally well in predicting subsequent need for ICU admission in validation studies [8–12], but none has been tested in clinical practice for its ability to reduce treatment delays and improve outcomes [13].

View this table:
  • View inline
  • View popup
Table 1– Definition of severe community-acquired pneumonia according to the 2007 Infectious Disease Society of America/American Thoracic Society community-acquired pneumonia guidelines

Delays in treatment and ICU admission for SCAP can lead to a disproportionate increase in mortality [14–17]. We showed in a validation study [9] that the 2007 IDSA/ATS minor criteria were accurate in predicting ICU admission in patients who did not initially require mechanical ventilation/vasopressor support. Subsequently, other well-conducted studies have reported similar results [10, 12, 18]. We also showed in another retrospective study that a delay in ICU admission was associated with less aggressive resuscitation in the emergency department [15], and that the presence of three or more minor criteria was associated with increased mortality. This suggested that admission decisions based on the minor criteria for SCAP might prevent treatment delay and reduce mortality [15, 17].

The impact of more aggressive treatment guided by pneumonia scores on clinically important outcomes in SCAP has not been evaluated previously. Hence, we conducted the present study to determine the effect of employing the IDSA/ATS 2007 minor criteria to guide emergency department triage and resuscitation, on all-cause hospital mortality, ICU admission rate and compliance with emergency department resuscitation.

Methods

Study design

This before-and-after study was divided into a control group (January 2004 to December 2007) and an intervention group (January 2008 to December 2010), and performed in our 1000-bed university-affiliated hospital. It was reviewed and approved by our research ethics committee (National Healthcare Group Domain Specific Review Board). Patient consent was not required as it was a retrospective observational study.

Target patient population and subgroups

We defined CAP as an acute pulmonary infection, presenting with an acute infiltrate on chest radiography and at least two of the following: fever (≥38°C), hypothermia (<36°C), rigors, new cough or change in colour of respiratory secretions, and chest discomfort or dyspnoea [3]. Patients who were hospitalised within 14 days of symptom onset, were immunocompromised or had tuberculosis were excluded.

Our target SCAP population was defined as CAP that fulfilled at least three IDSA/ATS minor criteria at emergency department presentation [4]. This group is at risk of deterioration, especially if the initial treatment or site of care was inappropriate. Patients with two or fewer minor criteria admitted to the ICU or the general ward, any IDSA/ATS major criteria and “do not resuscitate” (DNR) orders were excluded.

The target population was further divided into subgroups for analysis: direct ICU admissions (from emergency department to ICU), delayed ICU admissions (from emergency department to general ward to ICU) and general ward admissions (from emergency department to general ward).

Intervention

Before January 2008, the identification and management of SCAP was based on the clinical discretion of the individual physician. From January 2008, we implemented the intervention, a workflow that standardised the management of SCAP patients in the emergency department (fig. 1). The 2007 IDSA/ATS minor criteria were used to identify SCAP early and to guide a resuscitation bundle that was modified from the 2008 Surviving Sepsis Campaign guidelines [19]. The minor criteria did not dictate ICU admission as a default, but helped identify patients for aggressive treatment and consultations between the emergency department and ICU teams. Physicians were encouraged to exercise clinical judgement.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Workflow for managing severe community-acquired pneumonia (SCAP). IDSA: Infectious Diseases Society of America; ATS: American Thoracic Society; ICU: intensive care unit. #: patients who required vasopressors in the emergency department fulfilled major IDSA/ATS criteria for SCAP and were excluded from the main analysis.

The entire resuscitation bundle had to be completed within 6 h of emergency department presentation. Empirical antibiotics were administered within the first 3 h and provided coverage for SCAP organisms specific to the local context, such as Burkholderia pseudomallei [20]. We did not routinely insert central venous catheters for all SCAP patients at the emergency department unless vasopressors were required. Hence, central venous pressure and central venous oxygen saturation targets were excluded in the default resuscitation bundle. Patients who deteriorated and required intubation/vasopressors while receiving aggressive resuscitation in the emergency department were excluded.

Indication for ICU admission

Admission to the ICU versus the general ward was based on the ICU physician’s discretion. Briefly, patients with borderline physiological parameters after initial resuscitation, who might require intubation or vasopressors, were admitted to the ICU. Patients with three or more minor criteria who stabilised after initial resuscitation might be transferred to the general ward, with a nurse/patient ratio of 1/12 and managed by respiratory physicians. Patients with two or fewer minor criteria who were designated “at risk” by the emergency department physician received similar aggressive initial treatment and were then reviewed by the ICU physician. The decision for ICU admission was as described earlier, depending on the response to treatment. The medical ICU was a closed unit with a nurse/patient ratio of 1/2 and manned 24 h by intensivists.

Multidisciplinary collaboration

The intervention was designed and sustained by a multidisciplinary team, comprising representatives from both the respiratory–critical care medicine and emergency departments. The core group remained constant throughout the 7 years. The educational programme was supported by local champions in these departments, who trained nursing staff and physicians on the definitions and management of SCAP. All new staff underwent orientation tutorials on SCAP triage and sepsis guidelines. Posters and forms were designed and displayed prominently to facilitate compliance. Data on compliance were obtained by clinician nurses and reviewed every 2–4 weeks during business meetings and email discussions. Regular feedback was obtained to improve the workflow.

Data collection

All CAP admissions were prospectively recorded in an electronic database. Information gathered included demographics, comorbid illnesses, vital signs at the emergency department, initial laboratory and radiological findings, culture results, DNR orders, route of ICU admission and outcomes. Severity scores (Pneumonia Severity Index (PSI), 2007 IDSA/ATS minor criteria and Acute Physiology and Chronic Health Evaluation (APACHE) II) were calculated from these data. Data from the control group were collated from our earlier studies [9, 15] using medical record review by nurses, medical students and doctors. Similar methods were used for the intervention group.

Details of emergency department resuscitation were only collected for ICU admissions, because this information was unavailable for general ward admissions from our earlier studies. Antibiotic use was considered appropriate if the organism isolated was susceptible to the antibiotic used and the appropriate antibiotic combination was used in culture-negative cases.

Statistical analysis

We used the statistical software SPSS version 20 (SPSS Inc., Chicago, IL, USA). We compared categorical data using the Chi-squared or Fisher’s exact test and continuous data using the Mann–Whitney U-test or paired t-test where appropriate. Statistical significance was assumed at p<0.05.

To determine the independent predictors for mortality, univariate analyses comparing survivors with nonsurvivors were first performed on the following variables: study group, disposition (direct ICU admission/delayed ICU admission/general ward admission), age, sex, nursing home residency, comorbid illnesses, vital signs, laboratory and radiological findings, antibiotic appropriateness, PSI and APACHE II. Variables with p<0.10 and not used to calculate PSI were then entered into a forward logistic regression model for multivariate analysis: study group, disposition, diabetes mellitus, platelet count, antibiotic appropriateness and PSI. To determine whether disposition affected mortality, we repeated the logistic regression analysis in both the direct and delayed ICU admission subgroups using the same variables, except disposition was excluded and APACHE II was included to adjust for severity on ICU admission.

Results

3173 CAP patients were admitted from 2004 to 2010. We targeted 348 SCAP patients with three or more minor criteria for main analysis (fig. 2).

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

Differences in site of care and route of intensive care unit (ICU) admission between the study groups. CAP: community-acquired pneumonia; GW: general ward; IDSA: Infectious Disease Society of America; ATS: American Thoracic Society; DNR: do not resuscitate; SCAP: severe CAP.

Baseline characteristics

Differences in baseline characteristics are shown in table 2. The PSI was slightly lower in the intervention group. Patients in the control group had more comorbid conditions, such as heart failure and chronic renal disease; mean urea levels were higher in the intervention group. The proportion of patients meeting each IDSA/ATS minor criterion was similar between groups. Microbiological aetiologies are summarised in table 3; fewer patients were culture-positive in the intervention group.

View this table:
  • View inline
  • View popup
Table 2– Differences in baseline characteristics
View this table:
  • View inline
  • View popup
Table 3– Summary of microbiological aetiologies

Effect on mortality and other improvements

Hospital mortality was lower in the intervention group compared with the control group (table 4). Multivariate analysis showed that the intervention group was associated with lower mortality (table 5).

View this table:
  • View inline
  • View popup
Table 4– Differences in clinical outcomes
View this table:
  • View inline
  • View popup
Table 5– Variables associated with hospital mortality on multivariate analysis

In the intervention group, fewer patients required mechanical ventilation and vasopressor support; hospital length of stay was also shorter (table 4).

Effect on ICU admission rates, route of ICU admission and compliance with emergency department resuscitation

The ICU admission and delayed ICU admission rates were reduced in the intervention group (table 4). Of those who required ICU admission, direct ICU admission rates increased from 39.6% to 61.8% (p=0.006). Of those who were admitted to the general ward initially, the proportion of delayed ICU admissions dropped from 40.4% to 19.5% in the intervention group (p<0.001).

Improvements were achieved in the emergency department resuscitation performance measures in the intervention group; more lactate checks, more fluid boluses and more timely and appropriate antibiotics were given (table 6).

View this table:
  • View inline
  • View popup
Table 6– Differences in compliance to emergency department resuscitation performance measures for intensive care unit admissions

Subgroup analysis

table 7 shows the outcomes between subgroups. In the direct ICU admission subgroup, fewer patients required vasopressor support in the intervention group. In the delayed ICU admission subgroup, the hospital mortality rate dropped by 43%; being in the intervention group was associated with lower mortality on multivariate analysis (table 5). In the general ward admissions subgroup, hospital length of stay dropped from 5 days to 4 days.

View this table:
  • View inline
  • View popup
Table 7– Differences in subgroup outcomes

The baseline characteristics for the subgroups are presented in online supplementary table S1. There were some interesting findings in the delayed ICU admission subgroup. First, the patients in the control arm were more hypoxaemic, with a median (interquartile range) PaO2/FIO2 ratio of 153.8 (80.3–207.9), much lower than the minor criteria threshold of 250. Secondly, the PSI (at initial emergency department presentation) was similar in both the control and intervention arms, but the APACHE II score (on ICU day 1) was significantly lower in the latter group.

Effect on the entire CAP population

For the entire CAP population (table 8), we found a higher DNR rate in the intervention group. No differences were apparent between the two groups in hospital mortality, ICU admission rate, or proportion of patients with two or fewer minor criteria requiring ICU admission. After excluding patients with DNR orders, there was a statistical difference in mortality. In patients with two or fewer minor criteria requiring ICU admission, there was a higher rate of direct ICU admissions.

View this table:
  • View inline
  • View popup
Table 8– Effect of on the entire community-acquired pneumonia population

Overall data on all SCAP patients, defined as those with 1) three or more minor criteria, 2) one or more major criteria, and 3) two or fewer minor criteria, admitted to the ICU are summarised in online supplementary tables S2 and S3. For the entire SCAP cohort, there was a reduction in hospital mortality, need for vasopressors, hospital length of stay and ICU length of stay in the intervention group.

Discussion

Using the 2007 IDSA/ATS minor criteria to identify at-risk SCAP patients for aggressive initial emergency department resuscitation was associated with a reduction in hospital mortality, fewer ICU admissions and shorter length of stay. This may be related to better recognition (fewer delayed ICU admissions) and compliance with the resuscitation protocol. We found no evidence that the intervention harmed patients outside the study group: there were no differences in mortality for the entire CAP cohort and the proportion of “milder” SCAP cases (two or fewer minor criteria requiring ICU admission) were similar. The higher DNR rate in the intervention group may have led to fewer futile ICU admissions and partly, thus, to the mortality reduction. The intervention might allow the emergency department–ICU team to pick up cases in which aggressive care may be inappropriate. We enrolled SCAP patients with three or more IDSA/ATS minor criteria because we wanted to determine whether their excess risk might be mitigated by early aggressive treatment. Targeting this at-risk group specifically may have contributed to the mortality reduction, as early intervention benefited them the most.

Aggressive pre-ICU treatment may lead to better outcomes. Recently, a multicentre observational study by Miller et al. [21] reported that after implementing a resuscitation bundle, hospital mortality for severe sepsis and septic shock declined from 21.2% to 8.7% over 7 years. Better compliance to resuscitation bundles reduced the subsequent need for other organ support. Similarly, we report a decline in hospital mortality from 23.8% to 5.7% over the same timeframe. Other improvements suggest that our intervention was effective. First, ICU admission rates dropped from 52.9% to 38.6%, and this may have been due to better treatment and prevention of multiorgan dysfunction necessitating ICU care. Secondly, in the delayed ICU admission subgroup, despite both study arms having similar disease severity at emergency department presentation (similar PSI), by the time of ICU admission, the intervention group was notably less sick (lower APACHE II score), implying that the intervention may have prevented subsequent deterioration. As a result, this subgroup experienced the largest absolute mortality risk reduction of 43%; fewer patients required mechanical ventilation and vasopressors. Thirdly, those who were successfully treated in the general ward similarly benefited from a shorter hospital length of stay. Thus it is not delayed ICU admission [14–16] but delayed treatment that may contribute to additional mortality in SCAP. Better recognition and emergent management of borderline SCAP patients may reduce mortality and the need for ICU care [22].

Our intervention comprised two components to minimise treatment delays: 1) early identification of at-risk SCAP patients using the IDSA/ATS minor criteria; and 2) a resuscitation protocol. Effectively, this linked recommendations from both pneumonia [3, 4] and sepsis guidelines [19]. The minor criteria score was chosen as it had been widely validated for SCAP and is easy to use. We showed that this score might improve triage accuracy in clinical practice because it reduced delayed ICU admission rates. However, contrary to the IDSA/ATS recommendation [4], we did not admit all cases having three or more minor criteria into the ICU. Liapikou et al. [18], in their validation study, showed that ICU admission based on the IDSA/ATS minor criteria alone would require further investigation. This might also increase the number of inappropriate ICU admissions, as 50% of patients with three or more minor criteria may not require ICU admission [9]. Interestingly, we found that by using the minor criteria to guide aggressive treatment and not to determine ICU admission, we managed to reduce ICU admissions. Another concern was that SCAP patients with two or fewer minor criteria could be deprived of appropriate treatment, since its sensitivity was only 57% (95% CI 46–68%) in a systematic review by Marti et al. [8]. However, the proportion of patients with two or fewer minor criteria who required ICU admission did not drop. Instead, there was an increase in direct ICU admissions, similar to those with three or more minor criteria. Rather than searching for the “ideal score” to guide ICU admission, we should focus on how to use SCAP severity scores effectively to identify at-risk SCAP patients for timely management.

The second component of the intervention was a resuscitation bundle initiated in the pre-ICU setting. Currently, pneumonia guidelines do not emphasise the importance of achieving time-sensitive resuscitation targets in SCAP, although sepsis studies [21, 23, 24] have consistently demonstrated this to be effective in reducing mortality. Conflicting evidence also exists regarding the usefulness of early antibiotics for SCAP [1, 25]. Logically, to achieve outcome improvements, identifying SCAP patients early would not suffice; thus, the pragmatic incorporation of a resuscitation bundle might have improved the outcomes significantly.

The successful implementation of the intervention depended on a close-knit emergency department–medical ICU collaboration. The workflow was facilitated by the same core team over the entire 7 years. Thus we managed to ensure sustainability, one of the challenges encountered in many sepsis studies [23, 26]. We demonstrated that an interdisciplinary collaboration can facilitate initiation of timely emergent treatment in the pre-ICU setting [22, 27] and lead to an improvement in clinically important outcomes over time.

This study suffers from many important limitations. The “true” mortality reduction is probably lower. First, the intervention group may comprise “milder cases”, as the PSI score and the incidence of culture-positive cases were lower. However, the lower PSI score may be related to the lower comorbid burden in this group, as the mean IDSA/ATS scores in the two groups were similar. The significant reduction in mortality cannot be fully explained by the mild difference in PSI scores, which was apparent even after including PSI in the multivariate analysis. In addition, the relationship between culture positivity and disease severity is controversial [28]. Secondly, the mortality reduction may be spuriously lowered by bias and confounders that cannot be adjusted fully by statistical tools. Nonetheless, the mortality reduction signal is strong, the multidisciplinary team had remained constant, and information bias was limited using the same definitions and auditing process throughout the study. Thus, we felt that the improvement is less explained by minor differences in microbiological aetiologies, staff changeover and the introduction of new antibiotics and equipment. Thirdly, due to the study design, we could not assess whether the reduction of hospital mortality was related to early identification of at-risk SCAP cases, an aggressive resuscitation protocol or both. Fourthly, we did not compare data for compliance with emergency department resuscitation for general ward admissions because we did not collect this information in our previous studies [9, 15], which made up the control group. Lastly, the study period may be considered long. However, the study period is similar that used by Miller et al. [21]; a shorter study period may not yield sufficient numbers to demonstrate statistical significance. SCAP is also a complex problem and the sustained improvement in outcomes supports the clinical feasibility of our intervention.

In conclusion, the main strength of this study is its novel yet pragmatic approach of a combined intervention using the IDSA/ATS minor criteria to identify at-risk SCAP patients for timely emergent treatment with a resuscitation protocol. Despite the methodological limitations, we believe that the intervention may improve outcomes. More multidisciplinary collaboration and prospective trials are needed to critically evaluate this intervention in the pre-ICU setting.

Acknowledgments

We would like to thank Z. Bin Ab Hamid and G.B. Ooi (Emergency Dept, National University Health System, Singapore) for their tremendous effort in the education of emergency department staff and implementation of the sepsis bundles. Special thanks are also extended to the following for their help in data collection: D. Agrawal, D. Huang, Y.M. Khor, J. Lee and R.A. Tan (Dept of Medicine, National University Health System, Singapore), G.S. Kew and S.H. Lee (Yong Loo Lin School of Medicine, National University of Singapore, Singapore) and the nursing students from Ngee Ann Polytechnic (Clementi, Singapore).

Footnotes

  • This article has supplementary material available from www.erj.ersjournals.com

  • Conflict of interest: None declared.

  • Received May 12, 2013.
  • Accepted October 10, 2013.
  • ©ERS 2014

References

  1. ↵
    1. Rodriguez A,
    2. Lisboa T,
    3. Blot S,
    4. et al
    . Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 2009; 35: 430–438.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Angus DC,
    2. Marrie TJ,
    3. Obrosky DS,
    4. et al
    . Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002; 166: 717–723.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Lim WS,
    2. Baudouin SV,
    3. George RC,
    4. et al
    . BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–iii55.
    OpenUrlFREE Full Text
  4. ↵
    1. Mandell LA,
    2. Wunderink RG,
    3. Anzueto A,
    4. et al
    . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27–S72.
    OpenUrlFREE Full Text
  5. ↵
    1. Charles PG,
    2. Wolfe R,
    3. Whitby M,
    4. et al
    . SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47: 375–384.
    OpenUrlAbstract/FREE Full Text
    1. España PP,
    2. Capelastegui A,
    3. Gorordo I,
    4. et al
    . Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174: 1249–1256.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Renaud B,
    2. Labarère J,
    3. Coma E,
    4. et al
    . Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 2009; 13: R54.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Marti C,
    2. Garin N,
    3. Grosgurin O,
    4. et al
    . Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care 2012; 16: R141.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Phua J,
    2. See KC,
    3. Chan YH,
    4. et al
    . Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009; 64: 598–603.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Brown SM,
    2. Jones BE,
    3. Jephson AR,
    4. et al
    . Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 2009; 37: 3010–3016.
    OpenUrlCrossRefPubMedWeb of Science
    1. Chalmers JD,
    2. Mandal P,
    3. Singanayagam A,
    4. et al
    . Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011; 37: 1409–1420.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Chalmers JD,
    2. Taylor JK,
    3. Mandal P,
    4. et al
    . Validation of the Infectious Diseases Society of America/American Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011; 53: 503–511.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Reilly BM,
    2. Evans AT
    . Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006; 144: 201–209.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Renaud B,
    2. Santin A,
    3. Coma E,
    4. et al
    . Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia. Crit Care Med 2009; 37: 2867–2874.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Phua J,
    2. Ngerng WJ,
    3. Lim TK
    . The impact of a delay in intensive care unit admission for community-acquired pneumonia. Eur Respir J 2010; 36: 826–833.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Restrepo MI,
    2. Mortensen EM,
    3. Rello J,
    4. et al
    . Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 2010; 137: 552–557.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Brown SM,
    2. Jones JP,
    3. Aronsky D,
    4. et al
    . Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia. Respirology 2012; 17: 1207–1213.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Liapikou A,
    2. Ferrer M,
    3. Polverino E,
    4. et al
    . Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 2009; 48: 377–385.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Dellinger RP,
    2. Levy MM,
    3. Carlet JM,
    4. et al
    . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Lee KH,
    2. Hui KP,
    3. Tan WC,
    4. et al
    . Severe community-acquired pneumonia in Singapore. Singapore Med J 1996; 37: 374–377.
    OpenUrlPubMed
  19. ↵
    1. Miller RR 3rd.,
    2. Dong L,
    3. Nelson NC
    . Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med 2013; 188: 77–82.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Ewig S,
    2. Torres A
    . Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J 2011; 38: 253–260.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Ferrer R,
    2. Artigas A,
    3. Levy MM,
    4. et al
    . Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299: 2294–2303.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Levy MM,
    2. Dellinger RP,
    3. Townsend SR,
    4. et al
    . The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38: 367–374.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Bruns AH,
    2. Oosterheert JJ,
    3. Hustinx WN,
    4. et al
    . Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28: 913–919.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Pollack CV Jr,
    2. Amin A,
    3. Talan DA
    . Emergency medicine and hospital medicine: a call for collaboration. Am J Med 2012; 125: 826.
    OpenUrl
  25. ↵
    1. Howell MD,
    2. Ngo L,
    3. Folcarelli P,
    4. et al
    . Sustained effectiveness of a primary-team-based rapid response system. Crit Care Med 2012; 40: 2562–2568.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Brun-Buisson C,
    2. Doyon F,
    3. Carlet J,
    4. et al
    . Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 1995; 274: 968–974.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 43 Issue 3 Table of Contents
European Respiratory Journal: 43 (3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia
Hui Fang Lim, Jason Phua, Amartya Mukhopadhyay, Wang Jee Ngerng, Mei Ying Chew, Tiong Beng Sim, Win Sen Kuan, Malcolm Mahadevan, Tow Keang Lim
European Respiratory Journal Mar 2014, 43 (3) 852-862; DOI: 10.1183/09031936.00081713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia
Hui Fang Lim, Jason Phua, Amartya Mukhopadhyay, Wang Jee Ngerng, Mei Ying Chew, Tiong Beng Sim, Win Sen Kuan, Malcolm Mahadevan, Tow Keang Lim
European Respiratory Journal Mar 2014, 43 (3) 852-862; DOI: 10.1183/09031936.00081713
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Systematic assessment of respiratory health in illness susceptible athletes
  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
Show more Original articles

Respiratory infections

  • Role of non-pharmaceutical interventions in bronchiolitis outbreaks
  • In critically ill patients, anti-anaerobic antibiotics increase risk of adverse outcomes
  • Biomarker assay to risk-stratify patients with respiratory tract infection
Show more Respiratory infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society